If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Unsure why a chunk of comments have been deleted from yesterday. My email:
Dear Hemogenyx,
There has been informal discussions about the possibility of the company delisting from the London stock exchange. As a shareholder I am wary of rumours via the forums where these conversations take place but feel concerned due to the recent shakedown that took place by traders after the fantastic news regarding IND Trials/CBR updates.
Is there any reason to be concerned as a shareholder regarding a change in listings or privatisation of the company? I have no interest in selling you see as I think the company is going to do groundbreaking things for AML, NHL and everything else it's been working on.
Thank you for your time,
Warmest regards,
Response:
We are not aware of anything you described. Please follow official announcements.
Vladislav Sandler, Ph.D., Co-founder and CEO
Hemogenyx Pharmaceuticals LLC
760 Parkside Ave., Ste. 212, Brooklyn, NY 11226
Phone: (347) 735-8380
vladislav.sandler@hemogenyx.com
- as what I wrote yesterday has been removed for what reason I really don't get. Usually refrain from putting private emails into this forum cause it's silly but it is odd for someone to delete my very short post yesterday.
As far as the company is concerned, they don't know what people are on about regarding delisting.
Gotta wait and see what formal news comes in.
Have a good day all
Main market not AIM. But valid concerns regarding LSE Market in its current state
Haha! This is great, got a nice feeling and I'm glad the information for the tech and pipeline has been updated :)
haywain, one of the only posts worth reading today in what feels like a torrential offload of drivel and hot headed ranting. i agree here with the quality of products and results being the ultimate factor in financial representation of treatment/company. it's getting too personal with people going round the bend about disgrace this and tales of funders radio silence and just making displays of panic like a pea**** with an agenda. frustrating as it might be let's see what the results bring in and less monotanous rants.
JHFH, I understand and acknowledge that you putting the facts on the table for the trolls who are incessant and damaging to any new shareholders. It's annoying cause it's Hemo tbh are smashing it and genuinely doing really well and FDA approved, amazing results with CBR and the CDX patent. There's too many people to compete with regarding the silly monotanous rubbish on here so it's a challenge to try and update the forum with useful and proactive information. Part of it is annoying cause you half expect people to research and see the significant milestones through recent RNS to base their investment on but most of the time is hype train quick buck people chatting nonsense and not willing to just read to understand. Genuinely appreciate the balance your trying to achieve here and the plan really would be that the shirt term riff raffle is meaningless because ultimately if the results we hope the company achieve happen then it's a ticking time bomb and it will be past. It's just boring in the short term. My point is your appreciated and don't lose it when people chat cr@p.
Agreed. Developmental news is the only thing if interest. The rest very boring. Back when updates occur.
I think something learnt and reinforced over the years here is how much wasted time a d meaningless chat that takes place on this forum. I am not devaluing those who have great input or insight based on experience in the field but it's a shame cause it just gets so boring reading this and I'm adding to it. We are all just waiting now to hear commencement of trials and updates on CDX and the incredibly versatile CBR. Appreciated that if people didn't pop in to try and diffuse people just trying to Slaig off the company it would just be a huge cespit. Turn over of share have hopefully passed so the reasoning for the recent events will hopefully play out as strategic to instill more value and ownership in the medium to long term for the company and shareholders. See you when news or interesting developments land and apologies for adding to the crud 👌
Hi MrI,
So prevail infoworks Partnership is still in play. Confirmed by the company in an email I made last night after people raised the question so I wanted to find out.
I have sent a following query to see if there was reason to do placing, if there was a lack of interest through partnership deals either by wider pharma or Hemo.
Hopefully have some light shed on what was really a surprising turn today. I guess the challenging thing about it is that it appears there has been some form of inside trading taken place regarding individuals on this board and the potentially fundraisers. This is pretty shocking.
See how this plays out, the scientific results are the next part in this bumpy road.
Haha food, Good*
Enjoyed 'Did they let you out for food behaviour' 😅
JHFH - thanks for sending examples of the tangible and very real game Hemogenyx has now entered regarding just their CAR-T theraphy.
Don't let the chat get under your skin. Will mean absolutely nothing and all that hot air from the people talking rubbish will be a distant memory.
So I like trying to figure out the hypothetical value of assets early stage to get an idea of their potential evaluation and then idea of contributing value of in this case Hemogenyx company value.
Been considering one of the recent posts regarding the successful results for instranasal administration for the numerous viral diseases.
I use Aiseek for the current market comparisons and this is a hypothetical deduction:
As specified, the antiviral market is lucrative and projected to grow due to the persistent threat of viral epidemics and pandemics. According to a report published by Fortune Business Insights, the global antiviral drugs market size was valued at USD 38.2 billion in 2026 and is projected to reach USD 44.2 billion by 2027.
Given that Hemogenyx's patent-protected CBR platform is an exciting development in this field with the potential for broad applications, it is possible that the company could capture a significant portion of this market. If we assume a relatively conservative market capture of 3%, this gives us a potential market value of USD 1.3 billion for their CBR platform by 2027. This value can further multiply if we consider its potential application in cancer treatment.
So on a hypothetical just considering the antiviral market for CBR applications it's very interesting indeed.
Bring on next week!
To next week 😎👌
Thanks to the regulars and some new faces with level words. Pretty insane developments announced the last week. Stay tuned.
Would be nice 🙂 little RNS on a deal to finally get us up and out of the doldrums of price manipulation. I still can't get over the recent CBR RNS. That is literally huge and the market applications ridiculous. Mind blowing stuff.
Hemos website? Didn't think it had. Still refers to itself as pre clinical
Ribit there was a sincere congratulations to the Hemogenyx team outlined in the recent FDA RNS. Think that is all that needs to be. It's only been 2 business days. It's Tuesday tomorrow. All in good time. It's safe I imagine to presume that good time will come very shortly.
With you on this my friend. Following notice of the lift I'm waiting for an RNS of substance outlining the next steps for CAR-T trials. 100% they will be preparing/already have strong plans regarding this so all we can do is sit tight and wait for the following news. We are clinical. That is amazing. Sit back and enjoy the ride and scientific developments 🙏
Very much looking forward to a follow up RNS hopefully outlining a partner and potential cash deal/milestone payment scenario
Boom 😎
Do you think we will ever move to NasDaq in the future?
Is about when hit the 50m mark then yeah? Hopefully with confirmation of good news this is really accelerated with II's